Overview

Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients

Status:
Suspended

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to look at the effectiveness of giving a new anti-HIV drug (AG1549) plus Viracept (nelfinavir) plus Combivir (a tablet containing zidovudine plus lamivudine) to HIV-infected patients who are not taking anti-HIV drugs.

Phase:

Phase 2

Details

Lead Sponsor:

Agouron Pharmaceuticals

Treatments:

Capravirine
Lamivudine
Lamivudine, zidovudine drug combination
Nelfinavir
Zidovudine